ATAI Life Sciences NV (FRA:9VC) Other Net Income (Loss) : €-3.93 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Other Net Income (Loss)?

ATAI Life Sciences NV's Other Net Income (Loss) for the three months ended in Mar. 2024 was €-1.57 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.93 Mil.

ATAI Life Sciences NV's quarterly Other Net Income (Loss) declined from Sep. 2023 (€-0.22 Mil) to Dec. 2023 (€-0.36 Mil) and declined from Dec. 2023 (€-0.36 Mil) to Mar. 2024 (€-1.57 Mil).

ATAI Life Sciences NV's annual Other Net Income (Loss) increased from Dec. 2021 (€-36.84 Mil) to Dec. 2022 (€-15.11 Mil) and increased from Dec. 2022 (€-15.11 Mil) to Dec. 2023 (€-3.29 Mil).

ATAI Life Sciences NV Other Net Income (Loss) Historical Data

The historical data trend for ATAI Life Sciences NV's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Other Net Income (Loss) Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

-6.22

-62.89

-36.84

-15.11

-3.29

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial													-0.97	-1.78	-0.22	-0.36	-1.57

ATAI Life Sciences NV Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.93 Mil.

ATAI Life Sciences NV Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV (FRA:9VC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

ATAI:USA ATAI:Mexico

Address

Wallstraße 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines